GlassScriptPhysician profile
Sudhan Nagarajan
NPI 1053574129
$4,060.83
in general payments reported to CMS, 2019-2025
7 companies · $1,674 in 2025
The $1,674 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,874 · 2020: $142 · 2022: $140 · 2023: $57.19 · 2024: $173 · 2025: $1,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,051 · Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,051.19 |
| Food and Beverage | $853.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,420.53 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Angiodynamics, INC. | $1,382.16 | 2019 | |
| Atricure, INC. | $743.48 | 2019-2024 | |
| Abiomed | $253.09 | 2025 | |
| Silk Road Medical, INC. | $192.22 | 2020-2022 | |
| Medtronic, INC. | $57.19 | 2023 | Venaseal |
| Boston Scientific Corporation | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudhan Nagarajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.